Alnylam Netherlands

Alnylam pipeline update: AMVUTTRA catalysts, outlook and profitability

U.S. FDA · ATTR-CM · 5 min

Alnylam pipeline momentum is anchored by AMVUTTRA’s FDA-approved ATTR-CM and hATTR-PN uses, plus two active Phase 3 catalysts. The update focuses on what changed, what it means for investors, and what to watch next.